Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-18

Clinical Trial Update: Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Insulin Products / Long-term Treatment"

View source ↗

Summary

A completed clinical trial investigating the combined use of pioglitazone tablets with insulin products for long-term treatment of type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • pioglitazone tablets (pioglitazone)

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED | Results posted: 2019-02-18